Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT (Q35215038)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

title

Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

main subject

testosterone

1 reference

based on heuristic

inferred from title

testosterone

1 reference

based on heuristic

inferred from title

author

Laurence Klotz

series ordinal

1

object named as

Laurence Klotz

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

Larry Goldenberg

series ordinal

9

object named as

Larry Goldenberg

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

Celestia Higano

series ordinal

6

object named as

Celestia S Higano

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

author name string

Chris O'Callaghan

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

Keyue Ding

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

Paul Toren

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

David Dearnaley

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

Eric Horwitz

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

Shawn Malone

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

Mary Gospodarowicz

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

Juanita M Crook

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

language of work or name

English

0 references

publication date

2 March 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

published in

Journal of Clinical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

volume

33

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

issue

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

page(s)

1151-1156

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

cites work

Intermittent versus continuous androgen deprivation in prostate cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372851

retrieved

13 July 2018

Androgen deprivation therapy in advanced prostate cancer: is intermittent therapy the new standard of care?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372851

retrieved

13 July 2018

Intermittent androgen suppression for rising PSA level after radiotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372851

retrieved

13 July 2018

Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372851

retrieved

13 July 2018

Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: prognostic significance?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372851

retrieved

13 July 2018

Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372851

retrieved

13 July 2018

Individual variations of serum testosterone in patients with prostate cancer receiving androgen deprivation therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372851

retrieved

13 July 2018

Castration-recurrent prostate cancer is not androgen-independent

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372851

retrieved

13 July 2018

Effects of serum testosterone levels after 6 months of androgen deprivation therapy on the outcome of patients with prostate cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372851

retrieved

26 September 2018

Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: does it happen and does it matter?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372851

retrieved

26 September 2018

Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4372851

retrieved

26 September 2018

Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/25732157

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent endocrine therapy for advanced prostate cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/25732157

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1200/JCO.2014.58.2973

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

PMC publication ID

4372851

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

PubMed publication ID

25732157

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25732157

retrieved

7 August 2017

ResearchGate publication ID

273153871

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35215038&oldid=2186392568"